Xiaoli Fu

Title: Innovations of Xiaoli Fu in Pharmaceutical Research

Introduction

Xiaoli Fu is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative methods for preparing medicinal compounds. His work is characterized by a focus on improving the efficacy of treatments for cardiovascular diseases.

Latest Patents

Xiaoli Fu holds a patent for "Cycloastragenol monoglucoside, preparation, pharmaceutical composition and application thereof." This invention provides a method for preparing cycloastragenol monoglucoside (CMG), which involves several steps. The process begins with using astragaloside IV or Astragali extracts as raw materials, followed by hydrolysis with hydrolase at a constant temperature. The hydrolysate is then separated using macroporous adsorption resin, leading to the purification and separation of the final product. This innovative method not only enhances the preparation of cycloastragenol-6-O-β-D-glucoside but also supports its application in creating medicaments for treating cardiovascular diseases.

Career Highlights

Xiaoli Fu is affiliated with the Tianjin Institute of Pharmaceutical Research, where he continues to advance his research and development efforts. His dedication to innovation in pharmaceutical sciences has positioned him as a key figure in his field.

Collaborations

Xiaoli Fu collaborates with esteemed colleagues, including Yingmei Han and Weiren Xu. Their combined expertise fosters a productive research environment that enhances the development of new pharmaceutical solutions.

Conclusion

Xiaoli Fu's contributions to pharmaceutical research, particularly through his innovative patent, demonstrate his commitment to improving healthcare solutions. His work continues to impact the field positively, paving the way for advancements in the treatment of cardiovascular diseases.